March 7, 2024
Takeda Pharmaceutical said on March 6 that it has augmented its manufacturing line for Entyvio (vedolizumab) at the Hikari Plant in Yamaguchi Prefecture, western Japan, to more than triple its production capacity for the IBD drug. The company put up...read more